Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 14;22(4):22.
doi: 10.1007/s11886-020-1270-1.

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment

Affiliations
Review

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment

David Perez Ingles et al. Curr Cardiol Rep. .

Abstract

Purpose of review: The objective of this study is to explore the current literature supporting the use oral multivitamins and multi/minerals (OMVMs) for cardiovascular diseases (CVD) treatment and prevention.

Recent findings: Data on multivitamins, vitamin C and D, coenzyme Q, calcium, and selenium, has showed no consistent benefit for the prevention of CVD, myocardial infarction, or stroke, nor was there a benefit for all-cause mortality to support their routine supplementation. Folic acid alone and B vitamins with folic acid, B6 and B12, reduce stroke, whereas niacin and antioxidants are associated with an increased risk of all-cause mortality. Iron deficiency should be avoided and treated if found, but routine supplementation to those without deficiency is not evidence based. Despite the high supplement use by the general public, there is no evidence to support the routine supplementation of oral multivitamins and multi/minerals (OVMN) for CVD prevention or treatment.

Keywords: Cardiovascular disease; Supplements; Vitamins.

Similar articles

See all similar articles

References

    1. N Engl J Med. 2018 Oct 18;379(16):1540-1550 - PubMed
    1. Curr Atheroscler Rep. 2017 Jan;19(1):5 - PubMed
    1. J Am Coll Cardiol. 2014 May 6;63(17):1703-14 - PubMed
    1. J Gen Intern Med. 2004 Apr;19(4):380-9 - PubMed
    1. Pharmacol Res. 2015 Jan;91:1-8 - PubMed

LinkOut - more resources

Feedback